Close

Analyst Ratings for Mirati Therapeutics (MRTX)

MRTX Rating Summary

MRTX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on MRTX
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $103.80 (+48.6%) * Over Last 12-Mos
Rating Score: 7 / 10   Percentile Rank: 73%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/15/2022 Piper Sandler Swapnil Malekar New Coverage Overweight
(N/A)
110.00
(N/A)
82.98
(69.84)
-15.84% Details
8/2/2022 JPMorgan
» Updated 9/26/2022
Eric Joseph New Coverage Overweight
(N/A)
94.00
(109.00)
64.40
(69.84)
8.45% Details
Like MRTX Ratings? Also take a look at VSTM, ALNY, HZNP

MRTX Ratings News